Salazar

Quick links to important sections

Salazar

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salazar

Property Description
Active Ingredient Sulfasalazine (a chemical combination of Sulfapyridine and 5-Aminosalicylic Acid)
Form Oral (Tablets, Enteric-coated tablets)
Pharmacological Class Disease-Modifying Anti-Rheumatic Drug (DMARD)
General Purpose Management of chronic inflammation in autoimmune disorders
Origin Synthetic Derivative (Codrug)

What Type of Medicine is Salazar (Sulfasalazine)?

Salazar is a prescription medication whose active ingredient is Sulfasalazine (INN). It is categorized as both a Disease-Modifying Anti-Rheumatic Drug (DMARD) and a 5-Aminosalicylate Derivative. This dual classification reflects its general therapeutic purpose: to modify the course of chronic inflammatory diseases such as Rheumatoid Arthritis or specific forms of Inflammatory Bowel Disease. Sulfasalazine is clinically recognized for its long-term benefits in reducing disease activity, a finding supported by pharmacological studies. The drug helps control the systemic processes that drive chronic inflammation.


Composition and Available Forms of Sulfasalazine

The active component, Sulfasalazine, is a synthetic derivative designed as a prodrug, meaning it remains largely inactive until it undergoes a chemical change within the body. It is structurally a single molecule (a codrug) linking the therapeutic components Sulfapyridine and 5-Aminosalicylic Acid (5-ASA). The medication is primarily available for the oral route of administration as standard tablets or enteric-coated tablets (delayed-release tablets). The enteric coating is often used to ensure its delivery to the lower intestine for activation, where intestinal bacteria cleave the bond.


How Does Salazar Generally Benefit Chronic Inflammation?

Salazar's benefit stems from its unique dual-action delivery system. The general purpose of this mechanism is to provide comprehensive relief by delivering local anti-inflammatory effects directly in the gut lining (via 5-ASA) while simultaneously exerting systemic immunomodulatory properties (via absorbed Sulfapyridine) throughout the body. By helping to regulate the immune system's overactive response and reducing the factors that fuel chronic inflammation, Sulfasalazine is essential for the sustained, long-term control of autoimmune disorders in adult and pediatric patient groups.

What side effects are possible with Salazar?

Possible side effects and safety information

The safety profile of Salazar (Sulfasalazine) is formally classified by regulatory authorities using established frequency conventions, which detail the types and occurrence rates of possible adverse reactions.

Adverse Reaction Classifications

Adverse effects are documented across several System-Organ Classes, including Gastrointestinal Disorders (e.g., nausea, gastric distress), Nervous System Disorders (e.g., headache, dizziness), and Blood and Lymphatic System Disorders.

Classification Examples of Officially Listed Effects
Very Common (ge 10%) Headache, Nausea, Gastric Distress
Common (1% to 10%) Dizziness, Tinnitus, Fever, Pruritus, Leukopenia

Serious Adverse Reactions and Restrictions

Official labeling explicitly highlights the potential for Serious Adverse Reactions. These include life-threatening Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as severe Blood Dyscrasias (e.g., Agranulocytosis, Aplastic Anemia). These most serious risks are generally concentrated early in the course of therapy, often within the initial months of use, as documented in regulatory texts.

Safety restrictions formally prohibit use in individuals with known hypersensitivity to the drug, sulfonamides, or salicylates, and in those with porphyria or urinary obstruction. Regulatory documents also note specific population considerations, such as the potential for reversible oligospermia in males and an increased risk of hemolytic anemia in patients with G6PD deficiency. Additionally, the label documents that the medication may cause a non-serious yellow-orange discoloration of body fluids and skin.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Sulfasalazine (Salazar) requires immediate medical attention and is managed with supportive treatment, as no specific antidote is known. Regulatory information documents that the severity of toxicity is directly related to the total serum sulfapyridine concentration, a metabolic component of the drug.

Officially documented clinical manifestations of overdosage include gastrointestinal effects such as nausea, vomiting, abdominal pains, and gastric distress. In more advanced scenarios, Central Nervous System (CNS) symptoms like drowsiness and convulsions may be observed. The official labeling notes no documented reports of death resulting from the ingestion of large single doses.

Required Emergency Actions

Suspected overdose necessitates urgent medical intervention due to the potential for severe complications, including acute renal blockage by crystals (crystalluria). Regulatorily described procedures for management are symptomatic and supportive, and may involve gastric lavage, urinary alkalinization, and specific fluid management based on kidney function. If anuria (absence of urine output) is present, fluids and salt must be restricted. The low molecular weight of the drug and its metabolites facilitates their removal, meaning dialysis may be indicated. Monitoring the serum sulfapyridine concentration is required to track recovery progress.

Therapeutic Uses of Salazar

What Salazar Treats: Main Uses and Benefits

Salazar is generally used for managing chronic inflammatory conditions and is commonly used across conditions presenting with Rheumatoid Arthritis (RA) in adults, Polyarticular Juvenile Idiopathic Arthritis (JIA) in children, and mild to moderate active Ulcerative Colitis. In various clinical contexts, the medication is applied across domains where additional symptomatic support is needed. It plays a role in managing symptom clusters that may become intense or disruptive, such as significant joint swelling, tenderness, prolonged morning stiffness, bloody diarrhea, and abdominal pain related to active colitis.

Applied in these contexts, the medication provides long-term support that helps ease the overall symptom burden, whether related to chronic inflammatory joint conditions or the gastrointestinal symptoms of colitis. This supportive therapeutic benefit may assist in limiting the progression of structural joint damage and contributes to the feeling of functional stability during episodes of heightened discomfort.


Contextual Note: Management of Symptom Patterns Salazar is commonly used to help with persistent inflammatory joint symptoms (swelling, tenderness) and to address active symptoms of colonic inflammation (rectal bleeding, pain) associated with specific autoimmune disorders.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Profile for Salazar (Sulfasalazine)

The population eligibility profile for Salazar is strictly defined by regulatory documents based on contraindications and patient characteristics.

Contraindications (Must Not Use)

Salazar is formally prohibited for patients with a known hypersensitivity to sulfasalazine, its metabolites, sulfonamides, or salicylates. Use is also contraindicated in individuals with intestinal or urinary obstruction and those diagnosed with the metabolic disorder porphyria.

Age-Related Eligibility

The medicine is strictly contraindicated in all pediatric patients under two years of age. For the treatment of Juvenile Idiopathic Arthritis, its use is not established in children younger than six years old. Older adult patients should be noted for a potentially prolonged plasma half-life, though the clinical impact is listed as unknown.

Conditional and Restricted Use

Regulatory labeling specifies that administration to patients with pre-existing hepatic damage, renal damage, or certain blood dyscrasias requires critical appraisal before initiation. Use during pregnancy is classified as Category B and mandates high-dose folic acid supplementation. It is not recommended for use in newborns due to specific risks associated with breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Salazar (Sulfasalazine) establishes specific restrictions and monitoring requirements when used with certain other medications, supplements, or specific patient conditions. These restrictions are primarily classified into metabolic, absorption, and pharmacodynamic domains.

Contraindicated and High-Risk Combinations

Classification Interacting Substance/Condition
Contraindicated Methenamine (Risk of crystalluria)
Contraindicated Porphyria (Risk of acute attack)

Clinically Significant Interactions

Salazar may affect the levels of co-administered medicines through enzyme activity. It is a known inhibitor of thiopurine methyltransferase (TPMT), which can lead to increased exposure and heightened risk of hematologic toxicity (e.g., leukopenia) when combined with Azathioprine or Mercaptopurine. Reduced plasma levels of Digoxin have also been reported due to impaired absorption.

In the area of supplements, Salazar inhibits the absorption and metabolism of Folic Acid, which can lead to folate deficiency. Co-administration with Iron supplements may reduce the absorption of Salazar itself by forming chemical complexes (chelates). Furthermore, use with Oral Anticoagulants may result in impaired hepatic metabolism of the anticoagulant.

Mechanism of Action

The mechanism of Sulfasalazine relies on the complementary, dual action of its two active metabolites, 5-Aminosalicylic Acid (5-ASA) and Sulfapyridine (SP), following its cleavage as a prodrug by colonic bacteria.

Systemic Modulation of Pro-inflammatory Immune Signals

This domain, primarily mediated by absorbed Sulfapyridine, focuses on the regulation of the immune response by inhibiting the activation of the NF-kappa B transcription factor. This action limits the genetic coding and subsequent release of critical pro-inflammatory cytokines ( TNF-alpha, IL-6), which alters the underlying systemic immune response activity.

Localized Anti-inflammatory Enzyme Inhibition

The action of 5-Aminosalicylic Acid (5-ASA), released in the colon, is characterized by the inhibition of enzymes in the Arachidonic Acid Cascade ( COX and 5-LO). This modulation limits the synthesis of local inflammatory mediators like prostaglandins and leukotrienes and involves scavenging Reactive Oxygen Species (ROS), which decreases tissue inflammatory processes and fluid accumulation.

Mechanistic Synergy via Dual Delivery

The prodrug structure ensures the release of 5-ASA for a localized anti-inflammatory effect in the lower GI tract, alongside the systemic absorption of Sulfapyridine to provide sustained immunomodulatory activity. This synergy contributes to a comprehensive alteration of both localized tissue inflammatory mechanisms and systemic immune regulatory pathways.

Dosage and Administration Information

Administration Guidelines for Salazar (Sulfasalazine)

The following information describes the general administration guidelines for Salazar.

Administration Scope

Guideline Details
Route of Administration Oral (tablets, suspension) and Rectal (suppository).
Timing Relative to Meals Must be taken with or immediately after meals to minimize gastrointestinal discomfort.
Special Condition Maintain adequate fluid intake with each dose to reduce the risk of crystalluria and kidney stone formation.

Dosage and Preparation

Standard dosing specifies taking the total daily dose in multiple, evenly spaced intervals (e.g., 2 to 6 times daily). For adults, maintenance dosing is commonly 2 grams per day, following an initial titration period. Pediatric dosing for children 6 years and older is weight-based (mg/kg of body weight per day) and is divided into several doses.

Preparation requirements state that delayed-release, enteric-coated tablets must be swallowed whole and must not be crushed, broken, or chewed. This ensures the correct drug delivery and absorption.

Missed Dose Instructions

If a dose is missed, take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped to avoid taking a double dose. The patient should then return to the regular dosing schedule.

Recent Clinical Evidence

Overview of Studies for Chronic Inflammatory Conditions

Research on Salazar (Sulfasalazine) for its primary uses is largely based on Randomized Controlled Trials (RCTs) and long-term observational follow-up studies. For Adult Rheumatoid Arthritis (RA), studies monitored outcomes related to physical discomfort, functional scales (like the ACR criteria), and inflammatory markers (such as CRP and ESR). Researchers also applied longer-term studies to examine how physical damage to the joints evolved over time. Findings describe patterns observed in the study cohorts, though the evidence varies because early trials showed heterogeneity in their design. A limitation noted in the long-term findings is the observation that a notable number of participants stopped taking the medication.

For Ulcerative Colitis (UC), Salazar was evaluated in clinical trials for the management of mild to moderate active colitis and for maintenance of remission. Research examined symptomatic outcomes (bloody diarrhea and abdominal pain) and used objective endoscopic measures to track changes in the state of the colon tissue.

Evidence for Juvenile Idiopathic Arthritis (JIA) focuses primarily on polyarticular and certain oligoarticular forms in children. Studies observed responses over defined time intervals, using specialized pediatric criteria and collecting patient-reported outcomes describing perceived discomfort.


Long-Term Data, Special Groups, and Research Gaps

Follow-up research has been studied for its long-term effects, often focusing on the prevention of flare-ups in UC and the structural progression of RA. These long-term assessments are sometimes based on observational cohort studies, which means the certainty for drawing definitive conclusions is lower than from controlled trials.

Evidence in special patient groups is limited. For JIA, the evidence base is limited for children younger than six years of age. Research providing insight into special populations, such as older adults with significant comorbidities, is also limited compared to the general adult population. Furthermore, data for certain groups remain insufficient, including patients with systemic-onset JIA and specific severity strata of UC. The research provides context but does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Sulfasalazine - StatPearls (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Salazar (FAQ)


Q: How quickly does Salazar usually start to work after the first dose?

Studies indicate that Salazar is a disease-modifying medicine that works over time, not immediately. For conditions like Rheumatoid Arthritis, the official information suggests that a clinical effect typically appears within one to two months after starting treatment. The exact timing can vary depending on the specific condition being treated.


Q: Why do some official documents mention a certain risk classification for Salazar?

Regulatory documents focus attention on certain risks because life-threatening events, such as severe skin reactions and blood disorders, are most likely to occur early in therapy. Official labeling indicates that close medical monitoring should be considered during the initial months of use, as this is the period when the risk is generally considered highest.


Q: Can people with liver or kidney issues use Salazar?

Official labeling indicates that this medication has the potential to cause or worsen pre-existing kidney or liver problems. For this reason, the drug’s use for individuals with such damage should be determined after a critical medical review. The official prescribing information states that monitoring kidney and liver function tests should be conducted both before and periodically throughout the treatment course.


Q: Is there a generic version of Salazar available, or is it brand-only?

The active ingredient in Salazar is sulfasalazine, and generic versions of the tablets are available. These generic products are reviewed and approved by government health agencies, indicating they are considered comparable in terms of quality and performance to the original brand-name medication.


Q: Are there any known foods or drinks that should be avoided when taking Salazar?

Official information specifies that the drug should be taken with or immediately after meals, and that adequate fluid intake is noted as important. While no food-specific interactions are listed, the consumption of alcohol may increase the likelihood of experiencing side effects such as nausea or dizziness and is associated with a potential for increased risk to the liver or kidneys.


Q: Does Salazar cause weight gain or weight loss?

Weight change is not listed among the most common adverse reactions to the medication. However, official prescribing information does report decreased weight as a less common side effect associated with the use of this medication.


Q: How long is the typical treatment period with Salazar?

Salazar is a type of medicine intended for the long-term control of chronic inflammatory conditions. For diseases like Ulcerative Colitis or Rheumatoid Arthritis, it is often prescribed as a maintenance therapy. The purpose of long-term use is to prevent the flare-ups and relapses of the underlying condition.


Q: I'm feeling better; is it okay to stop taking Salazar?

Regulatory documentation emphasizes that continued maintenance administration is noted as important to help reduce the risk of symptom relapse for chronic conditions. Discontinuation of this medication, even when symptoms improve, should only occur under the guidance of a healthcare provider.


Q: Do older adults (seniors) need a different approach to using Salazar?

Studies in older adult patients show that the medication's half-life in the blood may be prolonged, which means the drug stays in the system longer. Although the clinical consequence of this is listed as unknown in official documents, healthcare providers may recommend closer monitoring for older individuals.


Q: Is Salazar considered a controlled substance?

According to regulatory drug classifications, this medication is not designated as a controlled substance. Official prescribing information states that no drug abuse or dependence has been reported for this medication.


Q: Can Salazar affect my ability to drive or operate machinery?

Official safety documents indicate that Salazar can cause central nervous system side effects, including dizziness, headache, and drowsiness. If you experience these reactions, your ability to safely drive or operate heavy machinery may be impaired.


Q: What if I take too much Salazar? What are the signs of accidental overdose?

The signs of accidentally taking too much Salazar may include symptoms such as nausea, vomiting, or gastric distress. In more serious cases, central nervous system effects like drowsiness or convulsions have been reported.


Q: Is Salazar safe to use during pregnancy or while breastfeeding?

Official prescribing information classifies this medicine as Pregnancy Category B. The label describes the need for high-dose folic acid supplementation during pregnancy because the drug may inhibit folic acid absorption. Use for newborns is generally advised against due to official concerns regarding specific risks associated with breastfeeding.


Q: Why is Salazar not recommended for people with a history of heart problems?

While a history of general heart problems is not a direct contraindication, official safety documents highlight that severe, though rare, hypersensitivity reactions can occur. These reactions may involve internal organs and have included reports of myocarditis, which is inflammation of the heart muscle.


Q: Are there different strengths or forms (like liquid vs. tablet) of Salazar available?

The medication is available in several forms and strengths for administration. These include standard oral tablets and enteric-coated tablets, which delay the release. It is also available as an oral suspension (liquid) and as rectal suppositories.


Q: Is it true that Salazar can cause changes in mood or sleep?

Yes, official safety information reports that the medication may be associated with central nervous system side effects. These reactions have included reports of mental depression and insomnia, or difficulty sleeping.


Q: What are the signs that Salazar might not be working for me?

Since Salazar is a long-term treatment, clinical benefit may not be observed right away, sometimes taking between 4 and 12 weeks. If you notice a lack of symptomatic improvement or if your disease activity appears to worsen, these may be signs that the medication is not working as expected.


Q: Why do some people experience initial side effects that later go away?

It is common to experience gastrointestinal side effects when first beginning treatment. Official texts advise that these initial effects often resolve when the medication is started at a lower dose and then gradually increased over time to the full therapeutic amount.


Q: Is there a specific time of day that is better for taking Salazar?

The total daily dose is typically divided into multiple, evenly spaced doses throughout the day, and should be taken after meals. Regulatory guidance emphasizes that maintaining even spacing, often with a gap of no more than eight hours between the bedtime and morning dose, is important for consistent blood levels.


Q: Do studies suggest Salazar works differently for men versus women?

Studies outlined in the official prescribing information indicate that gender does not appear to affect how the medication is processed by the body. The rate and pattern of the drug's metabolism are generally consistent between men and women.


Q: Can Salazar make certain pre-existing medical conditions worse?

Regulatory safety warnings indicate that the drug has the potential to cause and worsen pre-existing liver or kidney damage and certain blood cell problems. The official label describes the need for caution when the drug is administered to patients who have conditions such as severe allergies or bronchial asthma.


Q: How long does Salazar stay in your system after the last dose?

The amount of time Salazar stays in the body is based on the half-life of its main components. Official prescribing information states that the half-life for the primary active component is typically between 10.4 and 14.8 hours.


Q: Is Salazar known to cause dependence or addiction?

Official regulatory documentation confirms that no drug abuse or dependence has been reported associated with the use of sulfasalazine.


Q: Are there any required tests or check-ups needed while on Salazar?

Regulatory documents describe a monitoring schedule that includes complete blood counts (CBCs) and liver function tests, which are performed before starting therapy and frequently during the first three to six months of treatment. Urinalysis and assessment of kidney function are also noted in the official prescribing information for periodic monitoring.


Q: Is the list of side effects in the official documents exhaustive?

The list of adverse reactions in the official documents is based on specific reports for the drug. However, due to the pharmacological similarities within the sulfonamide drug class, the official prescribing information advises that healthcare professionals should consider other known reactions associated with that class.


Q: Why are people often told to use the lowest effective amount of Salazar?

Official documentation indicates that the risk of adverse effects increases when the daily dose exceeds a certain amount. The principle of using the lowest effective amount is a descriptive strategy aimed at finding the amount that controls the condition while helping to minimize the likelihood of side effects.


Q: What is the relationship between Salazar and other conditions I might have?

Regulatory information notes that caution is necessary for patients with conditions such as severe allergies or bronchial asthma. There is also specific mention of risk for those with G6PD deficiency, as this condition is associated with an increased chance of a side effect called hemolytic anemia.


Q: Is Salazar a drug that requires a special safety program?

According to the FDA, sulfasalazine is not categorized as a drug that requires a specialized safety program. It does not fall under the requirements of a Risk Evaluation and Mitigation Strategy (REMS).

How should Salazar be stored and disposed of?

Official Storage and Disposal Requirements

Salazar (sulfasalazine) must be stored and handled according to specific official instructions to maintain its stability and ensure safe disposal.

Storage & Disposal Scope Requirement
Storage Temperature Store at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). Protect from excess heat.
Protection Keep the medicine protected from moisture, humidity, and direct light. Do not store it in the bathroom, and keep it from freezing.
Packaging Keep the medication in its original container, tightly closed, to ensure its integrity and stability up to the expiration date.
Child Safety The medication must be kept strictly out of the sight and reach of children and pets.
Disposal Instructions Do not flush unused or expired Salazar down the toilet or throw it into household trash. The preferred method is to take it to an authorized drug take-back program or pharmacy collection site.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salazar found in:

A-Z Index: